| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/22/2010 | WO2010081849A1 Agent for preventing and treating pityriasis versicolor |
| 07/22/2010 | WO2010081835A2 Bis-resorcinyl-triazine derivatives as protecting agents against uv radiation |
| 07/22/2010 | WO2010081825A2 Pirenzepine as an agent in cancer treatment |
| 07/22/2010 | WO2010081823A1 Pirenzepine as otoprotective agent |
| 07/22/2010 | WO2010081817A1 Method for treating colorectal cancer |
| 07/22/2010 | WO2010081815A1 Aqueous coacervate composition comprising poorly water-soluble biologically-active agents |
| 07/22/2010 | WO2010081783A1 Novel specific inhibitors of ubiquitin specific protease 7, the pharmaceutical compositions thereof and their therapeutic applications |
| 07/22/2010 | WO2010081781A1 Energetic nutritional composition comprising a laxative, electrolytes and carbohydrates |
| 07/22/2010 | WO2010081778A1 Blockers of parp for the prevention and treatment of helicobacter pylori induced gastric cancer |
| 07/22/2010 | WO2010081692A1 Oxadiazole derivatives as slpl receptor agonists |
| 07/22/2010 | WO2010081683A1 Novel eicosanoid derivatives |
| 07/22/2010 | WO2010081666A1 Substituted heteroarylpiperidine derivatives as melanocortin-4 receptor modulators |
| 07/22/2010 | WO2010081662A2 Methods for identifying patients who will respond well to cancer treatment |
| 07/22/2010 | WO2010081647A2 Sgc stimulators of sgc activators in combination with pde5 inhbitors for the treatment of erectile dysfunction |
| 07/22/2010 | WO2010081623A1 Pharmaceutical formulation of nanonised fenofibrate |
| 07/22/2010 | WO2010081622A2 Food supplement for the treatment of neuropathies |
| 07/22/2010 | WO2010081488A1 Nitric oxide furoxan derivative compounds endowed with antitumoral activity |
| 07/22/2010 | WO2010081486A1 Compounds effective against cancer |
| 07/22/2010 | WO2010081387A1 N-substituted phenyl-3-methylene heterocyclic aryl-2,5-dimethylpyrrole compounds and anti-hiv/aids uses thereof |
| 07/22/2010 | WO2010081342A1 Methods for the preparation of ivabradine sulfate and form i crystal thereof |
| 07/22/2010 | WO2010081341A1 The crystal form i of n-n-propyl-3-(4-methylphenyl) -4-(methylsulfonylphenyl)-2,5-dihydropyrrole-2-one and the preparation method thereof |
| 07/22/2010 | WO2010081286A1 Timing controlled – release porous tablet of diltiazem hydrochloride and the preparation method thereof |
| 07/22/2010 | WO2010081266A1 A new use of tetrahydropalmatine |
| 07/22/2010 | WO2010081264A1 Pharmaceutical composition for preventing and treating diabetic nephropathy and preparation method thereof |
| 07/22/2010 | WO2010081263A1 A pharmaceutical composition for treating diabetic nephropathy and the preparation method and use thereof |
| 07/22/2010 | WO2010081262A1 A pharmaceutical composition for treating diabetic nephropathy and the preparation method and use thereof |
| 07/22/2010 | WO2010081259A1 A composition comprising extraction of fucoxanthin |
| 07/22/2010 | WO2010081257A1 Composition comprising bacillus calmette guerin polysaccharides and bacillus calmette guerin nucleic acids and use of preparing medicament thereof |
| 07/22/2010 | WO2010065743A3 Bicyclic compounds and methods of making and using same |
| 07/22/2010 | WO2010064785A3 Method for selectively crystallizing a z isomer of iopromide |
| 07/22/2010 | WO2010062927A3 Substituted octahydrocyclopnta (c) pyrrol-4 -amines as calcium channel blockers |
| 07/22/2010 | WO2010062523A3 Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereof |
| 07/22/2010 | WO2010062372A3 Methods for modulating nf-kb using gibberellins |
| 07/22/2010 | WO2010059004A9 Chemical inhibitor of p53-snail binding and pharmaceutical composition for treating cancer disease containing same as its active ingredient |
| 07/22/2010 | WO2010056907A3 Heterocyclic compounds that induce pancreatic beta-cell expansion |
| 07/22/2010 | WO2010055082A3 New crystal form of sunitinib malate |
| 07/22/2010 | WO2010053606A3 Small-molecule inhibitors of protein synthesis inactivating toxins |
| 07/22/2010 | WO2010048731A8 Aminoacyl trna-synthetase inhibitors as broad-spectrum immunosuppressive agents |
| 07/22/2010 | WO2010048332A3 Compounds for treating ophthalmic diseases and disorders |
| 07/22/2010 | WO2010047611A9 Process for preparing chlorins and their pharmaceutical uses |
| 07/22/2010 | WO2010045563A3 Combination therapies for the treatment of obesity |
| 07/22/2010 | WO2010045522A3 Combination therapies for the treatment of obesity |
| 07/22/2010 | WO2010045379A3 Pyridine non-classical cannabinoid compounds and related methods of use |
| 07/22/2010 | WO2010045292A3 Nanoparticle compositions comprising liquid oil cores |
| 07/22/2010 | WO2010042600A3 Photo-activatable therapeutic agents and methods of using |
| 07/22/2010 | WO2010040055A3 Oral pharmaceutical formulations for antidiabetic compounds |
| 07/22/2010 | WO2010039697A3 Selective inhibition of histone deacetylases 1 and 2 as a treatment for cardiac hypertrophy |
| 07/22/2010 | WO2010039518A3 Tricyclic carbamate jak inhibitors |
| 07/22/2010 | WO2010039289A3 Compounds and compositions for treating chemical warfare agent-induced injuries |
| 07/22/2010 | WO2010038965A3 GCH1-TARGETED si RNA, RECOMBINANT VECTOR CONTAINING si RNA, AND PHARMACEUTICAL COMPOSITION CONTAINING RECOMBINANT VECTOR FOR TREATING AND PREVENTING NEUROPATHIC PAIN |
| 07/22/2010 | WO2010038241A3 Pharmaceutical compositions comprising of proton pump inhibitor, prokinetic agent and alginic acid |
| 07/22/2010 | WO2010037095A3 Agents and methods for the treatment of cancer |
| 07/22/2010 | WO2010037059A3 Heteroaryl antagonists of prostaglandin d2 receptors |
| 07/22/2010 | WO2010036629A3 Fused multicyclic compounds as protein kinase inhibitors |
| 07/22/2010 | WO2010036052A3 Composition containing 4-o-methylhonokiol for treating or preventing amyloid- related diseases |
| 07/22/2010 | WO2010035273A3 Novel gastroretentive delivery system |
| 07/22/2010 | WO2010030667A3 Dosage forms for weakly ionizable compounds |
| 07/22/2010 | WO2010030201A3 Stable oral pharmaceutical composition containing a pharmaceutically acceptable salt of [(e)-7-[4-(4-fluorophenyl)-6-isopropyl-2- [methyl(methylsulfonyl)amino]pyrimidine-5-yl] (3r, 5s) - 3,5 dihydroxyhept-6- enoic acid |
| 07/22/2010 | WO2010028338A3 Novel compounds as cannabinoid receptor ligands |
| 07/22/2010 | WO2010028259A3 9-aminonoscapine and its use in treating cancers, including drug- resistant cancers |
| 07/22/2010 | WO2010025314A3 Prevention and treatment of itch with cysteine protease inhibition |
| 07/22/2010 | WO2010022196A3 [4-(5-aminomethyl-2-fluoro-phenyl)-piperidin-1-yl]-[7-fluoro-1-(2-methoxy-ethyl)-4-trifluoromethoxy-1h-indol-3-yl]-methanone as an inhibitor of mast cell tryptase |
| 07/22/2010 | WO2010021607A4 Pharmaceutical formulation |
| 07/22/2010 | WO2010020904A3 Cardioplegic preparation |
| 07/22/2010 | WO2010015692A3 Bupropion hydrobromide polymorphs |
| 07/22/2010 | WO2010015586A3 2,3,4,7-tetrahydro-indolo[2,3-c]quinoline compounds |
| 07/22/2010 | WO2010012745A3 Benzimidazoles |
| 07/22/2010 | WO2010011853A3 Beta-and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds |
| 07/22/2010 | WO2010009277A3 Immunogenic amphipathic peptide compositions |
| 07/22/2010 | WO2010007046A3 Heteroaryl derivatives as dgat1 inhibitors |
| 07/22/2010 | WO2009137728A3 Method for producing bicyclic guanidines by use of a cyclic urea |
| 07/22/2010 | WO2009137339A3 Therapeutic n-aryl or n-heteroaryl pyrazolidine and pyrazolidinone derivatives |
| 07/22/2010 | WO2009137100A3 Proguanil to treat skin/mucosal diseases |
| 07/22/2010 | WO2009124840A9 Compositions comprising myristic acid, fatty acids comprising a conjugated diene n‑5cis, n‑7trans or a conjugated triene n‑5cis, n‑7trans, n‑9cis |
| 07/22/2010 | WO2009112232A3 New drospirenone/17beta-estradiol regimen, pharmaceutical combination product and kit for performing this regimen |
| 07/22/2010 | WO2009093127A3 Substantially pure and a stable crystalline form of bosentan |
| 07/22/2010 | WO2009092278A8 Thienopyridazine compounds, their preparations, pharmaceutical compositions and uses |
| 07/22/2010 | WO2009080198A8 Fused cynopryridines and the use thereof |
| 07/22/2010 | WO2009076353A8 Compositions for protection against superficial vasodilator flush syndrome, and methods of use |
| 07/22/2010 | WO2009046398A3 Method for preparing stable hop powder |
| 07/22/2010 | WO2008155405A9 Crystalline solid forms |
| 07/22/2010 | US20100186102 Methods and compositions for post-transcriptional gene silencing |
| 07/22/2010 | US20100185226 Internal Clamp for Surgical Procedures |
| 07/22/2010 | US20100184984 Method of preparing 4-amino-1h-imidazo (4,5-c) quinolines and acid addition salts thereof |
| 07/22/2010 | US20100184870 Long-term stable pharmaceutical preparation containing the active ingredient glycerol trinitrate |
| 07/22/2010 | US20100184869 Method and kit for determining sirtuin modulating agents, sirtuin modulating procedure, sirtuin modulating compounds and compositions including the same |
| 07/22/2010 | US20100184868 Fortification of nutritional products with olive extracts containing hydroxytyrosol and hydroxytyrosol fortified nutritional products. |
| 07/22/2010 | US20100184866 Dual Cation Dual Anion Coordination Complexes |
| 07/22/2010 | US20100184865 Use Of RR/SR-Ractopamine |
| 07/22/2010 | US20100184864 Composite Material and Method for Production Thereof |
| 07/22/2010 | US20100184863 Synthetic spilanthol and use thereof |
| 07/22/2010 | US20100184862 Prostacyclin derivatives |
| 07/22/2010 | US20100184861 Method and apparatus for dry granulation |
| 07/22/2010 | US20100184860 Novel Carboxylic Acid and Antidepressant Composition Containing the Same as Active Ingredient |
| 07/22/2010 | US20100184859 Medicament having promoting action on hepatocyte proliferation |
| 07/22/2010 | US20100184858 Hepatic fibrosis inhibitor |
| 07/22/2010 | US20100184857 Administering fractions from hops (isohumulones) to ameliorate, inhibit or prevent gastropathy associated with a gastrointestinal irritant; prevents expression of COX-2 enzymatic activity in inflammatory cells, while having no effect on prostaglandin E; antiiulcer agents; antiinflammatory agents |
| 07/22/2010 | US20100184856 Novel Compounds and Uses Thereof for Treating Inflammation and Modulating Immune Responses |
| 07/22/2010 | US20100184854 Platinum (iv) complexes and methods of use thereof |
| 07/22/2010 | US20100184853 Terpenes with antifungal activity against malassezia yeasts |